PSTV vs SBAC · P/E 0.2, rev $5.8M vs P/E 30, rev $1.42B
Plus Therapeutics Inc (PSTV) versus SBA Communications Corp (SBAC) — a side-by-side from cached financials, not a winner call.
Plus Therapeutics Inc (PSTV) is a biotechnology company listed on NASDAQ.
SBA Communications Corp (SBAC) is a reit - specialty company listed on US.
Latest reported PSTV revenue for 2024-12-31 was $5.8M. Net income was -$13.0M. Revenue was up 18.5% from 2023-12-31 to 2024-12-31. PSTV currently screens at market cap $29.7M and trailing P/E 0.2.
Latest reported SBAC revenue for 2026-06-30 was $1.42B. Net income was $383.6M. SBAC currently screens at market cap $24.58B and trailing P/E 30.3.
PSTV currently screens at market cap $29.7M and trailing P/E 0.2. SBAC currently screens at market cap $24.58B and trailing P/E 30.3.
Not investment advice. Open the PSTV and SBAC stock pages for the full models.
Not investment advice.